Insulin Dependent Diabetes Mellitus
Conditions
Keywords
Strategies; Insulin; Injection; Hypertrophy; Map
Brief summary
Hypertrophy caused by insulin has effects that extend beyond just aesthetic concerns. Innovative methods have shown potential in decreasing the chances of hypertrophy and its related issues, including the development of detailed diagrams of insulin injection locations and tailored rotation plans. This study aimed to assess the impact of a novel insulin injection sites map (digital or physical) on the incidence of insulin-induced hypertrophy, adherence to rotation protocols, glycemic control, and patient experience among diabetes patients treated with insulin between study and control group along six months of follow up
Detailed description
Patients on long-term insulin therapy frequently experience significant side effect of insulin-induced hypertrophy, particularly lipohypertrophy (LH).Nurses play a crucial role as direct care providers and educators for diabetes patients, ensuring the safe administration of insulin and preventing insulin-related hypertrophy. This research aims to explore and evaluate innovative mapping methods for insulin injection locations due to the rising prevalence of diabetes in Egypt and the United States, alongside the considerable effect that insulin-induced hypertrophy has on patient results and healthcare systems
Interventions
PROCEDUREGroup(1) Insulin site injection map
The intervention group participants attended a structured educational session focused on strategies to reduce the risk of insulin-induced hypertrophy and its associated consequences, either individually or in small groups . The session included: appropriate insulin injection techniques, since repeated trauma is the main cause of hypertrophy, the researchers explained "standardized rotation protocols and insulin injection sites map"
Sponsors
Mansoura University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* • Type 1 or type 2 diabetes mellitus in adults (≥18 years old). * Insulin therapy has been administered for a minimum of six months. * Self-injecting insulin and assisted injection on a regular basis
Exclusion criteria
* Patients with mental illnesses or severe cognitive impairment. * Individuals with skin disorders at injection locations such as severe eczema, psoriasis, or infection that could interfere with the evaluation of lipohypertrophy. * Women who are lactating or pregnant.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Decrease Lipohypertrophy | 6 months | insulin induced lipohypertrophy |
Countries
Egypt
Contacts
STUDY_DIRECTORHala Mohamed Abdelhamed, Assis.prof
Faculty of Nursing, Mansoura university
STUDY_DIRECTORHoda Eldeeb, Assis.prof
Faculty of nursing, ِAlexandria University
Outcome results
None listed